ArticlePatient preference and adherence2018
Portable coagulometer for vitamin K-antagonist monitoring: the patients' point of view.
Article in Patient preference and adherence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.
- Point-of-care testing for non-communicable diseases and health literacy outcomes: a systematic review.BMC public health · 2026Pooled it
- Patients' satisfaction associated with portable coagulometers for warfarin monitoring: a cross-sectional study.Blood transfusion = Trasfusione del sangue · 2020Trial
- Living on Oral Anticoagulants: Duke Anticoagulation Satisfaction Scale Results.Journal of clinical medicine · 2023Article
- "It Was Very Comforting to Find Out Right Away." - Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care.Patient preference and adherence · 2022Article
- Point-of-care testing technologies for the home in chronic kidney disease: a narrative review.Clinical kidney journal · 2021Article
- Performance of the microINR Point-of-Care System Used by Self-Testing Patients: A Multicenter Clinical Trial.TH open : companion journal to thrombosis and haemostasis · 2021Article
- Thrombosis centres and AVKs monitoring in COVID-19 pandemic.Internal and emergency medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this study was to know the patients' point of view on the monitoring of vitamin K-antagonist (VKA) therapy by means of a point of care testing (POCT), ie, using a portable coagulometer by self-testing at home. At first, patients had prothrombin time (PT) international normalized ratio (INR) monitoring at a thrombosis center; afterward, they were shifted to self-testing at home. An interview was done to evaluate the patients' point of view on the two monitoring periods. PATIENTS AND
methodsA total of 92 oral anticoagulated patients were enrolled. The questionnaire contained nine questions that elicited a maximum of five closer answers that were arranged in increasing levels of satisfaction: very little, little, enough, much and completely. Percentage of time in therapeutic range (TTR) and adverse events were compared during the two periods of conventional monitoring and self-testing.
resultsThe period of conventional monitoring was shorter than that of self-testing (
conclusionVKA monitoring using POCT at home may play a role in improving the patients' quality of life and may be considered as an alternative to the use of DOAC at least in certain settings of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.